| Stage | CAT | % of rev | MTW | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $20.7B | 100.00% | $614M | 100.00% | CAT ×33.70 |
| Gross profit | $7.3B | 35.54% | $122M | 19.84% | CAT +15.7pp |
| Operating income | $4.2B | 20.38% | $32M | 5.18% | CAT +15.2pp |
| Pre-tax income | $4.2B | 20.40% | $19M | 3.06% | CAT +17.3pp |
| Net income | $3.3B | 15.89% | $11M | 1.79% | CAT +14.1pp |
| Stage | CAT | MTW | Gap · A − B |
|---|---|---|---|
| Revenue | $20.7B100.00% | $614M100.00% | CAT ×33.70 |
| Gross profit | 35.54%$7.3B | 19.84%$122M | CAT +15.7pp |
| Operating income | 20.38%$4.2B | 5.18%$32M | CAT +15.2pp |
| Pre-tax income | 20.40%$4.2B | 3.06%$19M | CAT +17.3pp |
| Net income |
| 15.89%$3.3B |
| 1.79%$11M |
| CAT +14.1pp |
No disclosed counterparties: MTW.
None